📰 Compass Pathways News
Page 44 - Compass Pathways News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Compass Pathways. Real-time updates on events, politics, business and more.
January 20, 2021
Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals.
January 20, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation ... Newscope Capital CorporationJanuary 19, 2021 GMT TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and development of psych...
January 20, 2021
Havn is one of the companies weâve discussed plenty of times in the past. One of the things that initially attracted attention was its Chairman of the Board of Directors. Vic Neufeld assumed the role last year and brought with him a founderâs mentality. Most notably, Neufeld was credited with leading Aphria (NASDAQ: APHA) on its path of success during the early days of cannabis legalization. He now has put his focus on the psychedelic industry. However, Havn is obviously more than ju...
January 13, 2021
Psychedelic, or magic, mushrooms on display in a grow room at a farm in the Netherlands. (Photo: Peter Dejong, AP) To sign up for our daily newsletter covering the latest news, features and reviews, head HERE. For a running feed of all our stories, follow us on Twitter HERE. Or you can bookmark the Gizmodo Australia homepage to visit whenever you need a news fix. A man’s experiment with psychedelic mushrooms went disastrously wrong and nearly killed him, according to his doctors. In a new cas...
January 11, 2021
As the Focus on Psychedelic Stocks Increases, So Do the Valuations The only companies that have Phase 2 clinical trials now are Compass Pathways, Mind Medicine, Cybin, and Mydecine Innovations. With so many new IPOs and companies launching in the psychedelic industry its important to fully evaluate the major factors of success or failure in the industry. There are various steps that companies take to have a drug approved and to successfully complete them it takes years and tens of milli...
January 8, 2021
Investegate announcements from Compass Pathways, Correction: COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care
January 8, 2021
to accelerate research and improve patient experience in mental health care London, UK – 8 January 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, is establishing its first Centre of Excellence in collaboration with The Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore, Maryland, United States. The Centre of Excellence will mod...
January 7, 2021
Thanks to biotech-focused drug development, the emerging psychedelic industry is stronger than ever before. However, there is a hidden hero in the details of the numerous press releases pertaining to psychedelic medicine progress – the investment banks allowing this space to grow. Indeed, the sheer scale of psychedelic medicine’s agenda requires a lot of funding, and much of this funding is thanks to investment banks who enter agreements with psychedelic medicine companies. Though ther...
January 1, 2021
Over the long term (more like decades), a prediction like yours might eventually take place but its not going to happen in the next 365 days. Yes, old Venice eventually lost its 13th century financial supremacy to New York and London, and New York City lost its film industry to Hollywood California. Therefore, Silicon Valleys dominance wont last forever but theyll still be the #1 tech hub in December 31 2021. * FB releases a thin virtual reality headset Currently being teste...
December 31, 2020
This article by Gaurav Dubey was originally published on Microdose Psychedelic Insights and appears here with permission. 2020 has indeed brought forth unforeseen challenges into the world due to the global coronavirus pandemic. However, this year has also seen monumental victories for psychedelic medicine–a radical new hope for a brighter future. The current state of mental healthcare, which has been starkly exposed due to the pandemic, is seriously insufficient.There is a significant need...